Allergy Therapeutics (LSE:AGY) Long-Term Debt : £0.95 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Allergy Therapeutics Long-Term Debt?

Allergy Therapeutics's Long-Term Debt for the quarter that ended in Dec. 2023 was £0.95 Mil.

Allergy Therapeutics's quarterly Long-Term Debt increased from Dec. 2022 (£1.20 Mil) to Jun. 2023 (£26.44 Mil) but then declined from Jun. 2023 (£26.44 Mil) to Dec. 2023 (£0.95 Mil).

Allergy Therapeutics's annual Long-Term Debt declined from Jun. 2021 (£2.45 Mil) to Jun. 2022 (£1.50 Mil) but then increased from Jun. 2022 (£1.50 Mil) to Jun. 2023 (£26.44 Mil).

Allergy Therapeutics Long-Term Debt Historical Data

The historical data trend for Allergy Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Long-Term Debt Chart

Allergy Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Long-Term Debt

Get a 7-Day Free Trial

1.74

2.93

2.45

1.50

26.44

Allergy Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															1.87	1.50	1.20	26.44	0.95

Allergy Therapeutics (LSE:AGY) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Allergy Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Allergy Therapeutics (LSE:AGY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (LSE:AGY) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics (LSE:AGY) Headlines

No Headlines